Tivic Health Systems, Inc.

Equities

TIVC

US8887052095

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:00 2024-04-24 pm EDT 5-day change 1st Jan Change
1.11 USD -1.71% Intraday chart for Tivic Health Systems, Inc. -0.45% -38.33%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Transcript : Tivic Health Systems, Inc., 2023 Earnings Call, Mar 25, 2024
Tivic Health Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Tivic Health Announces Completion of Enrollment for Study of Novel Non-Invasive Bioelectronic Approach to Vagus Nerve Stimulation CI
Tivic Health®? Systems, Inc. Enters Exclusive Distribution Agreement with Top 10 Medical Product Distributor for Mass Market Retail CI
Tivic Health Systems, Inc. Announces Termination of Ryan Sabia as Chief Operating Officer CI
Tivic Health Systems, Inc. Announces Launch of Second Generation of Tivic ClearUP CI
Top Premarket Decliners MT
Tivic Health Systems Seeks M&A CI
Transcript : Tivic Health Systems, Inc., Q3 2023 Earnings Call, Nov 14, 2023
Earnings Flash (TIVC) TIVIC HEALTH SYSTEMS Posts Q3 Revenue $282,000 MT
Tivic Health Systems, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Top Premarket Gainers MT
Tivic Health Partners with Instep Health to Access over 2,500 Healthcare Providers and Their Patients CI
Tivic Health Systems Regains Compliance With Nasdaq's Minimum Bid Price Rule MT
Top Premarket Gainers MT
Tivic Health's Products to be Offered on AmerisourceBergen Marketplace MT
Tivic Health Systems, Inc. Signs Agreement with AmerisourceBergen for Retail Pharmacy Customers CI
Sector Update: Health Care Stocks Slipping Late Afternoon MT
Sector Update: Health Care MT
Tivic Health Systems Declares 1-for-100 Reverse Stock Split; Shares Fall MT
Top Midday Gainers MT
Tivic Health Funded Study Begins Enrollment for Novel Non-Invasive Bioelectronic Approach to Vagus Nerve Stimulation CI
Earnings Flash (TIVC) TIVIC HEALTH SYSTEMS Reports Q2 Revenue $161,000, vs. Street Est of $0.63M MT
Tivic Health Systems, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Transcript : Tivic Health Systems, Inc., Q2 2023 Earnings Call, Aug 14, 2023
Chart Tivic Health Systems, Inc.
More charts
Tivic Health Systems, Inc. is a commercial-stage health tech company advancing the field of bioelectronic medicine. The Company’s patented technology platform leverages stimulation on the trigeminal, sympathetic, and vagus nerve structures. Its non-invasive and targeted approach to the treatment of inflammatory chronic health conditions is intended to give consumers and providers drug-free therapeutic solutions with high safety profiles, low risk, and broad applications. The Company’s first commercial product, ClearUP, is an FDA approved handheld bioelectronic sinus device. ClearUP is clinically proven, doctor-recommended, and available through online retailers and commercial distributors. ClearUP is sold in the U.S. directly to consumers on various platforms and through reseller channels. The Company is also focused on its intellectual property (IP) portfolio and research programs related to vagus nerve stimulation to expand its applications in non-invasive bioelectronic medicine.
More about the company

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. TIVC Stock
  4. News Tivic Health Systems, Inc.
  5. Tivic Health Systems Prices Underwritten Public Offering; Shares Down Pre-Bell